Millennium Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,854
Closed -$85.9K 6255
2024
Q4
$85.9K Sell
12,854
-29,087
-69% -$256K ﹤0.01% 5501
2024
Q3
$422K Sell
41,941
-29,768
-42% -$434K ﹤0.01% 4960
2024
Q2
$1.12M Buy
71,709
+49,663
+225% +$832K ﹤0.01% 4026
2024
Q1
$483K Buy
22,046
+14,194
+181% +$315K ﹤0.01% 4848
2023
Q4
$152K Sell
7,852
-18,023
-70% -$329K ﹤0.01% 5245
2023
Q3
$477K Sell
25,875
-15,599
-38% -$281K ﹤0.01% 4696
2023
Q2
$765K Buy
41,474
+18,495
+80% +$437K ﹤0.01% 4236
2023
Q1
$665K Buy
22,979
+22,141
+2,642% +$589K ﹤0.01% 4424
2022
Q4
$23K Sell
838
-10,696
-93% -$406K ﹤0.01% 6015
2022
Q3
$633K Sell
11,534
-771
-6% -$42.3K ﹤0.01% 4748
2022
Q2
$676K Sell
12,305
-14,850
-55% -$546K ﹤0.01% 4718
2022
Q1
$1.01M Buy
27,155
+2,847
+12% +$102K ﹤0.01% 4506
2021
Q4
$591K Sell
24,308
-118
-0.5% -$3.95K ﹤0.01% 4900
2021
Q3
$1.1M Sell
24,426
-21,557
-47% -$904K ﹤0.01% 4564
2021
Q2
$2.15M Buy
45,983
+41,560
+940% +$2.12M ﹤0.01% 3875
2021
Q1
$245K Sell
4,423
-13,648
-76% -$830K ﹤0.01% 5363
2020
Q4
$1.12M Buy
18,071
+2,250
+14% +$138K ﹤0.01% 3663
2020
Q3
$926 Buy
+15,821
New +$1.17M ﹤0.01% 3197
2020
Q2
Sell
-4,866
Closed -$328K 4481
2020
Q1
$328K Sell
4,866
-15,130
-76% -$1.52M ﹤0.01% 3127
2019
Q4
$2.77M Buy
19,996
+14,946
+296% +$1.94M ﹤0.01% 2392
2019
Q3
$530K Buy
5,050
+2,975
+143% +$297K ﹤0.01% 3219
2019
Q2
$220K Buy
+2,075
New +$273K ﹤0.01% 3710
2019
Q1
Sell
-3,300
Closed -$307K 4235
2018
Q4
$307K Sell
3,300
-3,832
-54% -$547K ﹤0.01% 3203
2018
Q3
$1.33M Buy
7,132
+6,114
+601% +$1.74M ﹤0.01% 2705
2018
Q2
$427K Buy
+1,018
New +$343K ﹤0.01% 3234
2018
Q1
Sell
-669
Closed -$190K 3964
2017
Q4
$190K Buy
+669
New +$188K ﹤0.01% 3545

Other funds holding OPTN

Millennium Management's OPTN Position: Q1 2025 in Review

Millennium Management sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 12,854 shares — an estimated $85.9K sold.

Millennium Management first reported a position in OPTN in Q4 2017 and held it in 26 quarters. The position peaked at $2.77M in Q4 2019. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Millennium Management reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 12,854 OptiNose shares in Q1 2025, an estimated $85.9K.
  • Millennium Management first reported a position in OptiNose in Q4 2017 and held it in 26 quarters.
  • Millennium Management's OptiNose position peaked at $2.77M in Q4 2019.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.